AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
44,600,296
Share change
+226,955
Total reported value
$1,252,786,822
Put/Call ratio
134%
Price per share
$28.09
Number of holders
142
Value change
+$1,632,937
Number of buys
80
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q3 2019

As of 30 Sep 2019, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 142 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,600,296 shares. The largest 10 holders included BlackRock Inc., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, GREAT POINT PARTNERS LLC, Partner Fund Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, and Bellevue Group AG. This page lists 142 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.